Is the international staging system superior to the Durie–Salmon staging system? A comparison in multiple myeloma patients undergoing autologous transplant-Reference-Cited by-同舟云学术

Is the international staging system superior to the Durie–Salmon staging system? A comparison in multiple myeloma patients undergoing autologous transplant

Published:2009-03-26 Issue:8 Volume:23 Page:1528-1534
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Hari P N,Zhang M-J,Roy V,Pérez W S,Bashey A,To L B,Elfenbein G,Freytes C O,Gale R P,Gibson J,Kyle R A,Lazarus H M,McCarthy P L,Milone G A,Pavlovsky S,Reece D E,Schiller G,Vela-Ojeda J,Weisdorf D,Vesole D

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu200961.pdf

Reference23 articles.

1. Durie BG, Salmon SE . A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer 1975; 36: 842–854.

2. Greipp PR, San Miguel J, Durie BG, Crowley JJ, Barlogie B, Blade J et al. International staging system for multiple myeloma. J Clin Oncol 2005; 23: 3412–3420.

3. Merlini G, Waldenstrom JG, Jayakar SD . A new improved clinical staging system for multiple myeloma based on analysis of 123 treated patients. Blood 1980; 55: 1011–1019.

4. Bataille R, Durie BG, Grenier J, Sany J . Prognostic factors and staging in multiple myeloma: a reappraisal. J Clin Oncol 1986; 4: 80–87.

5. Blade J, Rozman C, Cervantes F, Reverter JC, Montserrat E . A new prognostic system for multiple myeloma based on easily available parameters. Br J Haematol 1989; 72: 507–511.

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiple myeloma: 2024 update on diagnosis, risk‐stratification, and management;American Journal of Hematology;2024-06-28

2. Development and validation of a machine learning-based postoperative prognostic model for plasma cell neoplasia with spinal lesions as initial clinical manifestations: a single-center cohort study;European Spine Journal;2024-04-07

3. Comprehensive analysis of thirteen-gene panel with prognosis value in Multiple Myeloma;Cancer Biomarkers;2023-12-15

4. The loss of neoantigens is an important reason for immune escape in multiple myeloma patients with high intratumor heterogeneity;Cancer Medicine;2023-11-15

5. The role of staging in multiple myeloma;Expert Review of Hematology;2023-11-03